Sudha Sravanti Kotapalli

Author

Indian Institute of Chemical Technology

Also Known As

Kotapalli, Sudha Sravanti, S. S. Kotapalli, Sudha Sravanti Kotapalli

Publications

401

Citations

H-Index

Concepts

All Affiliations

Indian Institute of Chemical Technology Jawaharlal Nehru Technological University, Hyderabad Academy of Scientific and Innovative Research Birla Institute of Technology and Science, Pilani

About

Sudha Sravanti Kotapalli is an author at Indian Institute of Chemical Technology specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	372
2	Natural Sciences	5	5	177
3	Biochemistry	3	3	101
4	Biomolecular Engineering	1	1	26
5	Cell Biology	1	1	46

Sudha Sravanti Kotapalli

Publications

387

Citations

H-Index

Page 1

	Year	Citations
Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives Naveen Polkam, Parsharamulu Rayam, Jaya Shree Anireddy, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryAntimycobacterial EvaluationMedicineNatural Sciences	2015	55
Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents Narender Reddy Emmadi, Chiranjeevi Bingi, Sudha Sravanti Kotapalli, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntimicrobial Drug DiscoveryBioorganic ChemistryPharmaceutical ChemistryAntifungal Agent	2015	54
Investigation of triazole-linked indole and oxindole glycoconjugates as potential anticancer agents: novel Akt/PKB signaling pathway inhibitors Atulya Nagarsenkar, Santosh Kumar Prajapti, Sravanthi Devi Guggilapu, MedChemComm Triazole-linked IndolePharmacotherapyTumor BiologyMolecular PharmacologyMedicinal Chemistry	2016	50
Oxazolidinone derivatives: Cytoxazone–Linezolid hybrids induces apoptosis and senescence in DU145 prostate cancer cells Annavareddi Naresh, M. V. Basaveswara Rao, Sudha Sravanti Kotapalli, European Journal of Medicinal Chemistry Tumor BiologyOncologyMedicineCancer Cell BiologyCancer Biology	2014	46
Synthesis and biological screening of 2′-aryl/benzyl-2-aryl-4-methyl-4′,5-bithiazolyls as possible anti-tubercular and antimicrobial agents Yogita Abhale, Amit V. Sasane, Abhijit Chavan, European Journal of Medicinal Chemistry Antimicrobial Drug DiscoveryBioorganic ChemistryMedicineBiological ScreeningAntibacterial Agent	2015	37
Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents Y. Jayaprakash Rao, Thummala Sowjanya, Thirupathi Gogula, Molecular Diversity Medicinal ChemistryFlavone/isoxazole-annulated HeterocyclesAntifungal AgentMedicineAntimycobacterial Agents	2018	36
Expanding the tetrahydroquinoline pharmacophore Navya Goli, Prathama S. Mainkar, Sudha Sravanti Kotapalli, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryTetrahydroquinoline PharmacophoreMedicineNatural Sciences	2017	32
Design, synthesis and biological activity evaluation of novel pefloxacin derivatives as potential antibacterial agents Tejeswara Rao Allaka, Naveen Polkam, Parsharamulu Rayam, Medicinal Chemistry Research AntibioticsMedicineDrug DiscoveryAntibiotic AdjuvantNovel Pefloxacin Derivatives	2016	26
Identification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound Repository Sudha Sravanti Kotapalli, Sri Satya Anila Nallam, Lavanya Nadella, PLoS ONE Hit IdentificationTuberculosis PreventionPotential LeadsMolecular BiologyPharmaceutical Chemistry	2015	22
All‐Trans‐Retinoic Acid Stimulates Overexpression of Tumor Protein D52 (TPD52, Isoform 3) and Neuronal Differentiation of IMR‐32 Cells Sudha Sravanti Kotapalli, Chandrashekhar Dasari, Divya Duscharla, Journal of Cellular Biochemistry	2017	15

Page 1